Berberine: A Plant Alkaloid with Therapeutic Potential for Central Nervous System Disorders

被引:302
作者
Kulkarni, S. K. [1 ]
Dhir, Ashish [2 ]
机构
[1] Panjab Univ, Div Pharmacol, Univ Inst Pharmaceut Sci, Chandigarh 160014, India
[2] Univ Calif Davis, Med Ctr, Dept Neurol, Sacramento, CA 95817 USA
关键词
berberine; monoamines; neurological disorders; safety; CONGESTIVE-HEART-FAILURE; COPTIDIS-RHIZOMA EXTRACT; INDUCED DIABETIC-RATS; FORCED SWIM TEST; NITRIC-OXIDE; ANTIDEPRESSANT ACTIVITY; HIPPOCAMPUS; MECHANISM; EFFICACY; CHLORIDE;
D O I
10.1002/ptr.2968
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Berberine, an isoquinoline alkaloid of the protoberberine type found in an array of plants, has been used in Indian and Chinese medicines as an antimicrobial, stomachic, bitter tonic and in the treatment of oriental sores. Although pharmacological investigations of berberine have been reported by many in the past, there is renewed interest in berberine because of its reported beneficial effect in various neurodegenerative and neuropsychiatric disorders. The alkaloid is reported to modulate neurotransmitters and their receptor systems in the brain. This review attempts to discuss the pharmacological basis of the use of berberine in various central nervous system and related disorders. Its protective effect in Alzheimer's, cerebral ischemia, mental depression, schizophrenia and anxiety are highlighted. However, more detailed clinical trials along with a safety assessment of berberine are warranted for positioning the alkaloid in the treatment of neurological disorders. Copyright (C) 2009 John Wiley & Sons, Ltd.
引用
收藏
页码:317 / 324
页数:8
相关论文
共 58 条
[1]  
Anis K. V., 1999, Pharmacy and Pharmacology Communications, V5, P697
[2]   Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease Aβ secretion [J].
Asai, Masashi ;
Iwata, Nobuhisa ;
Yoshikawa, Ayumu ;
Aizaki, Yoshimi ;
Ishiura, Shoichi ;
Saido, Takaomi C. ;
Maruyama, Kei .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 352 (02) :498-502
[3]  
Birdsall T. C., 1997, Alternative Medicine Review, V2, P94
[4]  
CHAN E, 1993, BIOL NEONATE, V63, P201
[5]   DETERMINATION OF BERBERINE IN PLASMA, URINE AND BILE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
CHEN, CM ;
CHANG, HC .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 665 (01) :117-123
[6]  
CHOPRA RN, 1958, INDIGENOUS DRUGS
[7]   Recent development in studies of tetrahydroprotoberberines: Mechanism in antinociception and drug addiction [J].
Hongyuan Chu ;
Guozhang Jin ;
Eitan Friedman ;
Xuechu Zhen .
Cellular and Molecular Neurobiology, 2008, 28 (4) :491-499
[8]  
DASTUR JF, 1962, USEFUL PLANTS INDIA, P37
[9]   Neuroprotective effect of nimesulide, a preferential COX-2 inhibitor, against pentylenetetrazol (PTZ)-induced chemical kindling and associated biochemical parameters in mice [J].
Dhir, Ashish ;
Naidu, Pattipati S. ;
Kulkarni, Shrinivas K. .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2007, 16 (08) :691-697
[10]   Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test [J].
Dhir, Ashish ;
Kulkarni, S. K. .
PHARMACOLOGY, 2007, 80 (04) :239-243